WithdrawnNCT06735079
REL-1017 for depression
This study was withdrawn in Switzerland and in Italy. It is testing REL-1017 for depression.
Multiple locations, including MilanDepressionBehavioralFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00391222
Risperidone for Bipolarity
This study is completed in China, in Colombia, in Germany, .... It is testing risperidone for Bipolarity.
Multiple locations, including BaodingBipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
CompletedNCT02969382
SEP-363856 for schizophrenia
This study is completed in the United States, in Hungary, in Romania, .... It is testing SEP-363856 for schizophrenia.
Multiple locations, including Little RockSchizophreniaDrugFrom 18 Years to 40 Years
CompletedNCT00817648
Seroquel for schizophrenia
This study is completed in China. It is testing seroquel for schizophrenia.
Multiple locations, including ShanghaiSchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT01364662
SPN-810 for ADHD
This study is completed in the United States. It is testing SPN-810 for ADHD.
Multiple locations, including DothanADHDDrugFrom 6 Years to 12 Years
CompletedNCT00299715
Three Fixed Doses of Extended-release Paliperidone for Bipolarity
This study is completed. It is testing Three Fixed Doses of Extended-release Paliperidone for Bipolarity.
Location not clearly listedBipolarityDrugFrom 18 Years to 65 Years
CompletedNCT00531752
Two Doses of PF-03654746 for ADHD
This study is completed in the United States. It is testing Two Doses of PF-03654746 for ADHD.
Multiple locations, including LafayetteADHDDrugFrom 18 Years to 55 Years
CompletedNCT01725308
Efficacy of FK949E in Bipolarity people with Major Depressive Episodes
This study is completed in Japan. It is testing Efficacy of FK949E for depression.
Multiple locations, including AichiBipolarity, DepressionDrugFrom 20 Years to 64 Years
CompletedNCT01193153
Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
This study is completed in the United States, in Bulgaria, in India, .... It is testing efficacy of Paliperidone Palmitate for schizophrenia.
Multiple locations, including Garden GroveSchizophreniaDrugFrom 18 Years to 65 Years
UnknownNCT06399523
Efficacy of VR for Bipolarity
This study has an unknown status in China. It is testing Efficacy of VR for Bipolarity.
In ShanghaiBipolarityBehavioralOver 13 Years
CompletedNCT03434041
Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression
This study is completed in the United States and in China. It is testing flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
Multiple locations, including AtlantaDepressionDrugFrom 18 Years to 64 Years
CompletedNCT02918318
Fixed Doses of Intranasal Esketamine for treatment-resistant depression
This study is completed in Japan. It is testing fixed Doses of Intranasal Esketamine for treatment-resistant depression.
Multiple locations, including AkitaDepressionDrugFrom 20 Years to 64 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.